More or Less Medication: Is One Better than the Other?

Circ Cardiovasc Qual Outcomes. 2019 Apr;12(4):e005530. doi: 10.1161/CIRCOUTCOMES.119.005530.

Authors

Susan K Bowles^{1

2}, Melissa K Andrew^{3

2}

Affiliations

¹ College of Pharmacy and Department of Medicine (Geriatrics) (S.K.B.), Dalhousie University, Halifax, NS.
² Departments of Pharmacy and Medicine (Geriatrics) (S.K.B.), Nova Scotia Health Authority, Halifax, NS.
³ Department of Medicine (Geriatrics) (M.K.A.), Dalhousie University, Halifax, NS.

PMID: 31002000
DOI: 10.1161/CIRCOUTCOMES.119.005530

No abstract available

Keywords: Editorials; chronic disease; mortality; myocardial infarction; secondary prevention.

Publication types

Editorial
Comment

MeSH terms

Aged
Angiotensin-Converting Enzyme Inhibitors
Frail Elderly*
Humans
Myocardial Infarction*
Secondary Prevention

Substances

Angiotensin-Converting Enzyme Inhibitors